|
|
|
|
|
|
|
|
|
|
Molecular Scores to Predict Ovarian Cancer Outcomes: A Worthy Goal, but Not Ready for Prime Time
"... The premature application of inadequately validated biomarkers may adversely impact the successful implementation of individualized therapies."
Friday, April 13, 2012
open access: Editorial: Molecular Scores to Predict Ovarian Cancer Outcomes: A Worthy Goal, but Not Ready for Prime Time
Molecular Scores to Predict Ovarian Cancer Outcomes: A Worthy Goal, but Not Ready for Prime Time
"... The premature application of inadequately validated biomarkers may adversely impact the successful implementation of individualized therapies."
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.